|
|
||||||||||
|
J Am Coll Cardiol, 2002; 40:1459-1465 © 2002 by the American College of Cardiology Foundation |





,*
* Institute of Pharmacology, Halle, Germany
Clinic for Cardiothoracic Surgery, Martin-Luther-University of Halle-Wittenberg, Halle, Germany
Heart Center, Clinic for Cardiac Surgery, Leipzig, Germany
Departments of Pathophysiology and Nephrology, University of Essen School of Medicine, Essen, Germany
Manuscript received February 19, 2002; revised manuscript received May 7, 2002, accepted June 7, 2002.
* Reprint requests and correspondence: Dr. Otto-Erich Brodde, Department of Pathophysiology and Nephrology, University of Essen, School of Medicine, Hufelandstr. 55, D-45147, Essen, Germany.
otto-erich.brodde{at}medizin.uni-halle.de
OBJECTIVES: The purpose of this study was to elucidate whether the neuronal noradrenaline reuptake transporter (uptake1) undergoes age-dependent regulation in the human heart.
BACKGROUND: Aging is associated with various alterations in cardiovascular function.
METHODS: We determined uptake1 density (by [3H]-nisoxetine binding to membranes) and activity (by accumulation of [3H]-noradrenaline into tissue slices) in the right atria (RA) of 42 patients (age range 3 months to 76 years) undergoing open-heart surgery without apparent heart failure. Moreover, the effects of 1 µmol/l desipramine on the noradrenaline-induced positive inotropic effect were assessed in the isolated, electrically driven RA trabeculae of these patients.
RESULTS: There was a significant negative correlation between RA uptake1 density and age; moreover, RA uptake1 activity was significantly reduced in elderly patients. Desipramine (1 µmol/l) significantly shifted noradrenaline concentration-response curves to the left; this shift was significantly more pronounced in younger patients than in older patients.
CONCLUSIONS: With increasing age, human myocardial uptake1 activity decreases, possibly because of age-dependent downregulation of uptake1 density.
| ||||||||
This article has been cited by other articles:
![]() |
F. H. H. Leenen, A. Fourney, E. Coletta, and R. White Effects of hypertension on cardiovascular responses to epinephrine in humans Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3025 - H3031. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Munch, K. Rosport, A. Bultmann, C. Baumgartner, Z. Li, L. Laacke, and M. Ungerer Cardiac Overexpression of the Norepinephrine Transporter Uptake-1 Results in Marked Improvement of Heart Failure Circ. Res., October 28, 2005; 97(9): 928 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. Li, C. Holmes, I. J. Kopin, and D. S. Goldstein Aging-Related Changes in Cardiac Sympathetic Function in Humans, Assessed by 6-18F-Fluorodopamine PET Scanning J. Nucl. Med., October 1, 2003; 44(10): 1599 - 1603. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |